ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,214, issued on Dec. 9, was assigned to Merakris Therapeutics LLC (Hillsborough, N.C.).
"Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing" was invented by Thomas Christopher Broderick (Hillsborough, N.C.) and William Samuel Fagg IV (Galveston, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The described invention provides compositions and methods for wound healing in a subject. The methods include administering a therapeutic amount of a pharmaceutical composition comprising extracellular vesicles from amniotic fluid and a pharmaceutically acceptable carrier."
The patent was filed on Feb. 27, 2020, under Applicati...